These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Factors determining the long-term outcome of surgery for acromegaly. Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657 [TBL] [Abstract][Full Text] [Related]
8. Investigation of the criteria for assessing the outcome of treatment in acromegaly. Lindholm J; Giwercman B; Giwercman A; Astrup J; Bjerre P; Skakkebaek NE Clin Endocrinol (Oxf); 1987 Nov; 27(5):553-62. PubMed ID: 3450453 [TBL] [Abstract][Full Text] [Related]
9. Cryosurgery or microsurgery in the management of acromegaly. Teasdale GM; Hay ID; Beasttall GH; McCruden DC; Thomson JA; Davies DL; Grossart KW; Ratcliffe JG JAMA; 1982 Mar; 247(9):1289-91. PubMed ID: 7062545 [TBL] [Abstract][Full Text] [Related]
10. Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977. Laws ER; Piepgras DG; Randall RV; Abboud CF J Neurosurg; 1979 Apr; 50(4):454-61. PubMed ID: 423000 [TBL] [Abstract][Full Text] [Related]
11. Early post-operative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly. Bynke O; Karlberg BE; Kågedal B; Nilsson OR Acta Endocrinol (Copenh); 1983 Jun; 103(2):158-62. PubMed ID: 6858550 [TBL] [Abstract][Full Text] [Related]
12. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels. Biermasz NR; Dulken HV; Roelfsema F Clin Endocrinol (Oxf); 2000 Sep; 53(3):321-7. PubMed ID: 10971449 [TBL] [Abstract][Full Text] [Related]
13. Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value. De Marinis L; Mancini A; Zuppi P; Anile C; Maira G Acta Endocrinol (Copenh); 1990 Apr; 122(4):443-9. PubMed ID: 2110409 [TBL] [Abstract][Full Text] [Related]
14. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement? Valdemarsson S; Ljunggren S; Cervin A; Svensson C; Isaksson A; Nordström CH; Siesjö P Scand J Clin Lab Invest; 2001; 61(6):459-70. PubMed ID: 11681536 [TBL] [Abstract][Full Text] [Related]
16. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986 [TBL] [Abstract][Full Text] [Related]
17. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. Ross DA; Wilson CB J Neurosurg; 1988 Jun; 68(6):854-67. PubMed ID: 3373281 [TBL] [Abstract][Full Text] [Related]
18. Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery? van den Berg G; van Dulken H; Frölich M; Meinders AE; Roelfsema F Clin Endocrinol (Oxf); 1998 Jul; 49(1):45-51. PubMed ID: 9797846 [TBL] [Abstract][Full Text] [Related]
19. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery. Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628 [TBL] [Abstract][Full Text] [Related]
20. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]